Literature DB >> 29174375

Actinidia arguta extract attenuates inflammasome activation: Potential involvement in NLRP3 ubiquitination.

Kang-Hyuck Heo1, Xiao Sun1, Do-Wan Shim1, Myong-Ki Kim2, Sushruta Koppula3, Sang-Hyeun Yu1, Han-Bi Kim1, Tack-Joong Kim4, Tae-Bong Kang5, Kwang-Ho Lee6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Actinidia arguta (A. arguta) has been widely used in Asian countries as a traditional medicinal herb to treat inflammation-related diseases, such as gastritis, bronchitis, and arthritis. AIM OF THE STUDY: The inhibitory effect of A. arguta leaves' extract (AA) on inflammasome activation was investigated to verify its traditional use in treating inflammation-related diseases.
MATERIALS AND METHODS: Bone marrow-derived macrophages (BMDMs) primed by lipopolysaccharide (LPS) were activated by selective inflammasome stimulators, and the effect of AA on inflammasome activation was investigated. A monosodium urate crystal (MSU)-induced peritonitis mouse model was used to study the in vivo efficacy of AA on inflammasome activation.
RESULTS: In the in vitro study, AA regulated NLRP3 ubiquitination and apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization, leading to the inhibition of NLRP3 inflammasome-mediated interleukin (IL)-1β secretion. The inhibitory effect of AA on inflammasome activation in vitro was further confirmed in vivo using an MSU-induced peritonitis mouse model.
CONCLUSION: AA provided scientific evidence, substantiating the traditional claims for its use in the treatment of inflammation and inflammation-mediated metabolic disorders, including gout.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ASC; Actinidia arguta; Inflammasome; NLRP3; Peritonitis; Ubiquitination

Mesh:

Substances:

Year:  2017        PMID: 29174375     DOI: 10.1016/j.jep.2017.11.023

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  3 in total

Review 1.  Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications.

Authors:  Jianan Zhao; Kai Wei; Ping Jiang; Cen Chang; Lingxia Xu; Linshuai Xu; Yiming Shi; Shicheng Guo; Yu Xue; Dongyi He
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 2.  Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout.

Authors:  Jun Ho Lee; Hyuk Soon Kim; Jun-Ho Lee; Gabsik Yang; Hong Jun Kim
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

3.  Aromatic Constituents from the Leaves of Actinidia arguta with Antioxidant and α-Glucosidase Inhibitory Activity.

Authors:  Jong Hoon Ahn; Se Hwan Ryu; Solip Lee; Sang Won Yeon; Ayman Turk; Yoo Kyong Han; Ki Yong Lee; Bang Yeon Hwang; Mi Kyeong Lee
Journal:  Antioxidants (Basel)       Date:  2021-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.